428 related articles for article (PubMed ID: 24379610)
1. Target genes discovery through copy number alteration analysis in human hepatocellular carcinoma.
Gu DL; Chen YH; Shih JH; Lin CH; Jou YS; Chen CF
World J Gastroenterol; 2013 Dec; 19(47):8873-9. PubMed ID: 24379610
[TBL] [Abstract][Full Text] [Related]
2. Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma.
Guichard C; Amaddeo G; Imbeaud S; Ladeiro Y; Pelletier L; Maad IB; Calderaro J; Bioulac-Sage P; Letexier M; Degos F; Clément B; Balabaud C; Chevet E; Laurent A; Couchy G; Letouzé E; Calvo F; Zucman-Rossi J
Nat Genet; 2012 May; 44(6):694-8. PubMed ID: 22561517
[TBL] [Abstract][Full Text] [Related]
3. Genomic profiling of combined hepatocellular-cholangiocarcinoma reveals similar genetics to hepatocellular carcinoma.
Joseph NM; Tsokos CG; Umetsu SE; Shain AH; Kelley RK; Onodera C; Bowman S; Talevich E; Ferrell LD; Kakar S; Krings G
J Pathol; 2019 Jun; 248(2):164-178. PubMed ID: 30690729
[TBL] [Abstract][Full Text] [Related]
4. Overlapping high-resolution copy number alterations in cancer genomes identified putative cancer genes in hepatocellular carcinoma.
Chen CF; Hsu EC; Lin KT; Tu PH; Chang HW; Lin CH; Chen YJ; Gu DL; Lin CH; Wu JY; Chen YT; Hsu MT; Jou YS
Hepatology; 2010 Nov; 52(5):1690-701. PubMed ID: 20799341
[TBL] [Abstract][Full Text] [Related]
5. Genomic structures of dysplastic nodule and concurrent hepatocellular carcinoma.
Lee M; Kim K; Kim SY; Jung SH; Yoon J; Kim MS; Park HC; Jung ES; Chung YJ; Lee SH
Hum Pathol; 2018 Nov; 81():37-46. PubMed ID: 29949741
[TBL] [Abstract][Full Text] [Related]
6. Integrative analysis reveals novel driver genes and molecular subclasses of hepatocellular carcinoma.
Yang L; Zhang Z; Sun Y; Pang S; Yao Q; Lin P; Cheng J; Li J; Ding G; Hui L; Li Y; Li H
Aging (Albany NY); 2020 Nov; 12(23):23849-23871. PubMed ID: 33221766
[TBL] [Abstract][Full Text] [Related]
7. Multimodal Meta-Analysis of 1,494 Hepatocellular Carcinoma Samples Reveals Significant Impact of Consensus Driver Genes on Phenotypes.
Chaudhary K; Poirion OB; Lu L; Huang S; Ching T; Garmire LX
Clin Cancer Res; 2019 Jan; 25(2):463-472. PubMed ID: 30242023
[TBL] [Abstract][Full Text] [Related]
8. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
[TBL] [Abstract][Full Text] [Related]
9. Genomic analysis of liver cancer unveils novel driver genes and distinct prognostic features.
Li X; Xu W; Kang W; Wong SH; Wang M; Zhou Y; Fang X; Zhang X; Yang H; Wong CH; To KF; Chan SL; Chan MTV; Sung JJY; Wu WKK; Yu J
Theranostics; 2018; 8(6):1740-1751. PubMed ID: 29556353
[No Abstract] [Full Text] [Related]
10. Diverse modes of genomic alteration in hepatocellular carcinoma.
Jhunjhunwala S; Jiang Z; Stawiski EW; Gnad F; Liu J; Mayba O; Du P; Diao J; Johnson S; Wong KF; Gao Z; Li Y; Wu TD; Kapadia SB; Modrusan Z; French DM; Luk JM; Seshagiri S; Zhang Z
Genome Biol; 2014 Aug; 15(8):436. PubMed ID: 25159915
[TBL] [Abstract][Full Text] [Related]
11. A novel prognostic index of hepatocellular carcinoma based on immunogenomic landscape analysis.
Xiao H; Wang B; Xiong HX; Guan JF; Wang J; Tan T; Lin K; Zou SB; Hu ZG; Wang K
J Cell Physiol; 2021 Apr; 236(4):2572-2591. PubMed ID: 32853412
[TBL] [Abstract][Full Text] [Related]
12. Integrated exome sequencing and microarray analyses detected genetic defects and underlying pathways of hepatocellular carcinoma.
Chong ML; Knight J; Peng G; Ji W; Chai H; Lu Y; Wu S; Li P; Hu Q
Cancer Genet; 2023 Aug; 276-277():30-35. PubMed ID: 37418972
[TBL] [Abstract][Full Text] [Related]
13. Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification.
Calderaro J; Couchy G; Imbeaud S; Amaddeo G; Letouzé E; Blanc JF; Laurent C; Hajji Y; Azoulay D; Bioulac-Sage P; Nault JC; Zucman-Rossi J
J Hepatol; 2017 Oct; 67(4):727-738. PubMed ID: 28532995
[TBL] [Abstract][Full Text] [Related]
14. Next generation sequencing reveals genetic landscape of hepatocellular carcinomas.
Li S; Mao M
Cancer Lett; 2013 Nov; 340(2):247-53. PubMed ID: 23063663
[TBL] [Abstract][Full Text] [Related]
15. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H
J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
[TBL] [Abstract][Full Text] [Related]
16. Genetic Landscape and Biomarkers of Hepatocellular Carcinoma.
Zucman-Rossi J; Villanueva A; Nault JC; Llovet JM
Gastroenterology; 2015 Oct; 149(5):1226-1239.e4. PubMed ID: 26099527
[TBL] [Abstract][Full Text] [Related]
17. Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma.
Wang K; Lim HY; Shi S; Lee J; Deng S; Xie T; Zhu Z; Wang Y; Pocalyko D; Yang WJ; Rejto PA; Mao M; Park CK; Xu J
Hepatology; 2013 Aug; 58(2):706-17. PubMed ID: 23505090
[TBL] [Abstract][Full Text] [Related]
18. Genomic landscape of lymphoepithelioma-like hepatocellular carcinoma.
Chan AW; Zhang Z; Chong CC; Tin EK; Chow C; Wong N
J Pathol; 2019 Oct; 249(2):166-172. PubMed ID: 31168847
[TBL] [Abstract][Full Text] [Related]
19. Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.
Ding X; He M; Chan AWH; Song QX; Sze SC; Chen H; Man MKH; Man K; Chan SL; Lai PBS; Wang X; Wong N
Gastroenterology; 2019 Dec; 157(6):1630-1645.e6. PubMed ID: 31560893
[TBL] [Abstract][Full Text] [Related]
20. Accumulation of Molecular Aberrations Distinctive to Hepatocellular Carcinoma Progression.
Midorikawa Y; Yamamoto S; Tatsuno K; Renard-Guillet C; Tsuji S; Hayashi A; Ueda H; Fukuda S; Fujita T; Katoh H; Ishikawa S; Covington KR; Creighton CJ; Sugitani M; Wheeler DA; Shibata T; Nagae G; Takayama T; Aburatani H
Cancer Res; 2020 Sep; 80(18):3810-3819. PubMed ID: 32641413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]